Did you mean 301 2,3 3?
Displaying drugs 8576 - 8600 of 10976 in total
Dexloxiglumide
Dexloxiglumide is a selective cholecystokinin type A (CCKA) receptor antagonist in phase III testing by Rottapharm in Europe only, as U.S. trials have been discontinued. As the D-isomer of loxiglumide, it retains all pharmacological properties of loxiglumide but is more potent.
Investigational
Matched Iupac: … (4R)-4-[(3,4-dichlorophenyl)formamido]-4-[(3-methoxypropyl)(pentyl)carbamoyl]butanoic acid …
Ubamatamab
Ubamatamab is under investigation in clinical trial NCT03564340 (Study of REGN4018 Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers).
Investigational
Methylenedioxyethamphetamine
Experimental
Illicit
Matched Iupac: … [1-(2H-1,3-benzodioxol-5-yl)propan-2-yl](ethyl)amine …
Tyvelose
Experimental
2-Bromo-6-chloro-purine
Experimental
Matched Synonyms: … 2-Bromo-6-chloro-7H-purine …
Matched Name: … 2-Bromo-6-chloro-purine …
Matched Iupac: … 2-bromo-6-chloro-7H-purine …
Matched Name: … 2-Bromo-6-chloro-purine …
Matched Iupac: … 2-bromo-6-chloro-7H-purine …
Hydroxypropyl betadex
Hydroxypropyl betadex is under investigation in clinical trial NCT03471143 (Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C).
Investigational
Matched Synonyms: … 2-Hydroxypropyl-b-cyclodextrin ... 2-Hydroxylpropyl-beta-cyclodextrin ... 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN …
Matched Iupac: … [31.2.2.2^{3,6}.2^{8,11}.2^{13,16}.2^{18,21}.2^{23,26}.2^{28,31}]nonatetracontane-36,37,38,39,41,42,43,45,46,48 ... 36R,37R,38R,39R,40R,41R,42R,43R,45R,46S,47R,48S,49R)-5,10,25,35-tetrakis(hydroxymethyl)-40,47,49-tris(2- ... hydroxypropoxy)-15,20,30-tris[(2-hydroxypropoxy)methyl]-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo …
Matched Iupac: … [31.2.2.2^{3,6}.2^{8,11}.2^{13,16}.2^{18,21}.2^{23,26}.2^{28,31}]nonatetracontane-36,37,38,39,41,42,43,45,46,48 ... 36R,37R,38R,39R,40R,41R,42R,43R,45R,46S,47R,48S,49R)-5,10,25,35-tetrakis(hydroxymethyl)-40,47,49-tris(2- ... hydroxypropoxy)-15,20,30-tris[(2-hydroxypropoxy)methyl]-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo …
1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE
Experimental
Matched Name: … 1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE …
Matched Iupac: … 1-{[(4-chlorophenyl)carbamoyl]methyl}-N-[1-(propan-2-yl)piperidin-4-yl]-1H-indole-2-carboxamide …
Matched Iupac: … 1-{[(4-chlorophenyl)carbamoyl]methyl}-N-[1-(propan-2-yl)piperidin-4-yl]-1H-indole-2-carboxamide …
(S)-Mandelic acid
Experimental
Matched Synonyms: … (S)-2-Hydroxy-2-phenylacetic acid …
Matched Iupac: … (2S)-2-hydroxy-2-phenylacetic acid …
Matched Iupac: … (2S)-2-hydroxy-2-phenylacetic acid …
Serelaxin
Recombinant human relaxin is a hormone produced during pregnancy that facilitates the birth process by causing a softening and lengthening of the cervix and the pubic symphysis (the place where the pubic bones come together).It is a heterodimer protein secreted by the corpus luteum and placenta during pregnancy.
Investigational
Matched Synonyms: … Human relaxin 2 (relaxin h2) …
Seliciclib
R-roscovitine (Seliciclib or CYC202) is a cyclin-dependent kinase (CDK) inhibitor that preferentially inhibits multiple enzyme targets including CDK2, CDK7 and CDK9, which alter the growth phase of treated cells. Developed by Cyclacel, seliciclib is being researched for the treatment of non-small cell lung cancer (NSCLC), leukemia, HIV infection, herpes simplex...
Investigational
Matched Synonyms: … 2-(R)-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine …
Matched Iupac: … (2R)-2-{[6-(benzylamino)-9-(propan-2-yl)-9H-purin-2-yl]amino}butan-1-ol …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Iupac: … (2R)-2-{[6-(benzylamino)-9-(propan-2-yl)-9H-purin-2-yl]amino}butan-1-ol …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine
Experimental
Matched Name: … N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine …
Matched Iupac: … (2S)-2-amino-5-(N'-hydroxycarbamimidamido)pentanoic acid …
Matched Iupac: … (2S)-2-amino-5-(N'-hydroxycarbamimidamido)pentanoic acid …
Phosphoramidon
Experimental
Matched Iupac: … -4-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid ... (2S)-2-[(2S)-2-{[hydroxy({[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy})phosphoryl]amino} …
Methoserpidine
Experimental
Matched Iupac: … dimethoxy-17-(3,4,5-trimethoxybenzoyloxy)-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2( …
[N-[N-(4-Methoxy-2,3,6-trimethylphenylsulfonyl)-L-aspartyl]-D-(4-amidino-phenylalanyl)]-piperidine
Experimental
Matched Iupac: … (3S)-3-{[(2R)-3-(4-carbamimidoylphenyl)-1-oxo-1-(piperidin-1-yl)propan-2-yl]carbamoyl}-3-(4-methoxy-2,3,6 …
Dapirolizumab pegol
Dapirolizumab pegol is under investigation in clinical trial NCT02804763 (A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus).
Investigational
Matched Synonyms: … pegylated, anti-(homo sapiens cd40lg (cd40 ligand, cd40l, tumor necrosis factor ligand superfamily member 5, …
Matched Description: … Dapirolizumab pegol is under investigation in clinical trial NCT02804763 (A Phase 2 Efficacy and Safety …
Matched Description: … Dapirolizumab pegol is under investigation in clinical trial NCT02804763 (A Phase 2 Efficacy and Safety …
N(2)-succinyl-L-arginine
Experimental
Matched Name: … N(2)-succinyl-L-arginine …
Matched Iupac: … (2S)-5-carbamimidamido-2-[(3-carboxy-1-hydroxypropylidene)amino]pentanoic acid …
Matched Iupac: … (2S)-5-carbamimidamido-2-[(3-carboxy-1-hydroxypropylidene)amino]pentanoic acid …
Pyrrole-2-Carboxylate
Experimental
Matched Name: … Pyrrole-2-Carboxylate …
Matched Iupac: … 1H-pyrrole-2-carboxylic acid …
Matched Iupac: … 1H-pyrrole-2-carboxylic acid …
2-Aminobenzyl alcohol
Experimental
Matched Synonyms: … 2-Aminobenzenemethanol ... 2-Aminobenzyl alcohol …
Matched Name: … 2-Aminobenzyl alcohol …
Matched Iupac: … (2-aminophenyl)methanol …
Matched Name: … 2-Aminobenzyl alcohol …
Matched Iupac: … (2-aminophenyl)methanol …
Tralesinidase alfa
Tralesinidase alfa is a chimeric fusion protein comprised of recombinant human NAGLU and a modified human insulin-like growth factor 2. It is being investigated for the treatment of mucopolysaccharidosis type IIIB (MPS IIIB), also known as Sanfilippo syndrome B.
Investigational
Matched Synonyms: … Alpha-N-acetyglucosaminidase-insulin-like-growth-factor-2 fusion protein ... Recombinant human alpha-N-acetylglucosaminidase-insulin-like growth factor-2 …
Matched Description: … fusion protein comprised of recombinant human NAGLU and a modified human insulin-like growth factor 2. …
Matched Description: … fusion protein comprised of recombinant human NAGLU and a modified human insulin-like growth factor 2. …
8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide
Experimental
Matched Name: … 8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide …
Matched Iupac: … 8-[(pyrimidin-2-yl)amino]naphthalene-2-carboximidamide …
Matched Iupac: … 8-[(pyrimidin-2-yl)amino]naphthalene-2-carboximidamide …
2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine
Experimental
Matched Name: … 2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine …
Matched Iupac: … 2-(6-methylpyridin-2-yl)-N-(pyridin-4-yl)quinazolin-4-amine …
Matched Iupac: … 2-(6-methylpyridin-2-yl)-N-(pyridin-4-yl)quinazolin-4-amine …
N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE
Experimental
Matched Name: … N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE …
Matched Iupac: … N-[2-(6-amino-4-methylpyridin-2-yl)ethyl]-4-cyanobenzamide …
Matched Iupac: … N-[2-(6-amino-4-methylpyridin-2-yl)ethyl]-4-cyanobenzamide …
2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE
Experimental
Matched Name: … 2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE …
Matched Iupac: … [2-(naphthalene-2-sulfonamido)ethoxy]phosphonic acid …
Matched Iupac: … [2-(naphthalene-2-sulfonamido)ethoxy]phosphonic acid …
Displaying drugs 8576 - 8600 of 10976 in total